ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113237; 2) Community: the network communities that were significantly associated with the response to NSC 113237; 3) Molecule: the relationships between components within communities and NSC 113237; 4) MDR: the compounds that were significantly associated with the NSC 113237.

NSC Compound Enrichment Correlation
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.011265111688021 0.23227506
NSC 709974 Null 0.011265111688021 0.33473552
NSC 711077 Null 0.011265111688021 0.31772649
NSC 718781 Erlotinib hydrochloride 0.011265111688021 -0.23056664
NSC 726217 Combretastatin A4-analogue 0.011265111688021 0.29070659
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.011265111688021 0.30857266
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.011265111688021 0.48533198
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.011265111688021 0.45443775
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.011265111688021 0.24944379
NSC 753598 Null 0.011265111688021 0.30880871
Total:136  Current:57    [First] [Prev] [Next] [Last]